Khalid Alsulaiman Shared a New Study About Clinical Outcomes of Apixaban
Khalid Alsulaiman, Vice Chairman, Clinical Trial Management (CTM) at King Abdullah International Medical Research Center, shared a post on LinkedIn:
“Happy to share our new study titled: “*Evaluation of the Clinical Outcomes of Apixaban Use in Patients with Atrial Fibrillation and Uncontrolled Hypothyroidism: A Real-world Evidence*”, published in Clinical and Applied Thrombosis/Hemostasis.
In this study, we evaluated the effectiveness and safety of apixaban among patients with atrial fibrillation who also suffer from uncontrolled hypothyroidism. Our findings indicate that the use of apixaban in patients with AF and uncontrolled hypothyroidism was linked to higher rates of thrombosis and major bleeding compared to those without known hypothyroidism. These findings highlight the need for further research through larger prospective studies in this often-overlooked population.
We would like to thank all investigators who contributed to this project from the Saudi Critical Care Pharmacy Research (SCAPE) Platform, Saudi Society for Multidisciplinary Research Development and Education (SCAPE Society) and King Abdullah International Medical Research Center (كيمارك KAIMRC).”
Title: Evaluation of the Clinical Outcomes of Apixaban Use in Patients with Atrial Fibrillation and Uncontrolled Hypothyroidism: A Real-world Evidence
Authors: Khalid Al Sulaiman, Manal A Aljohani, Abdullah F Alharthi, Hisham A Badreldin, Mohammed Y Alzahrani, Rahaf A Alqahtani, Walaa A Alshahrani, Fatimah M Abudayah, Mohammad S Shawaqfeh, Ahmed A Alrashed, Alaa M Alenazi, Nouf S Alsagri, Mohammed Yahya Asiri, Zayed Asiri, Sulaiman Aljarallah, Yusuf M. Garwan, Lama S. Alfehaid, Abeer A. Alenazi, Tariq Aldebasi, Shmeylan Alharbi, Ahmed Aldemerdash, Amer Alzahrani, Ohoud Aljuhani
Read full article here.
Stay updated with Hemostasis Today.
-
Jun 1, 2026, 18:51Francesco Giurazza: New Publication on Glubran-2 in Acute Bleeding Patients with Coagulopathies
-
Jun 1, 2026, 18:50Donald Arnold is the Recipient of the Roberts Award – ISTH
-
Jun 1, 2026, 18:49Amirreza Jabbaripour Sarmadian: My First Paper as Corresponding Author on Upper Extremity DVT Following COVID-19 Vaccination
-
Jun 1, 2026, 18:49James P. Crowley: How Combining Vitamin D analogs with Chemotherapy Impacts Survival Outcomes
-
Jun 1, 2026, 18:42Debojyoti Chakraborty: Small But Meaningful Steps Toward A Gene Editing Trial For Sickle Cell Disease In India
-
Jun 1, 2026, 17:14Tiffany Gacel: What an Incredible Day With NBCA and The Red Bus Tour at Memorial at Gulfport?
-
Jun 1, 2026, 17:12Marie-Claire Kofi: Poster Highlights the Process of Establishing the Sickle Cell Transitions Policy Lab
-
Jun 1, 2026, 17:00Azusa Nagao: Organizing the Symposium on Women and Bleeding Disorders at JSTH Annual Meeting
-
Jun 1, 2026, 16:57Kuljeet Kaur: Approach to Anemia – More Than Just a Low Hemoglobin